Intelligence · Clinical Pipeline
Novo Nordisk A/S Pipeline
All ClinicalTrials.gov programs at Novo Nordisk A/S — phase, modality, and trial IDs.
- Programs
- 5
Quick answer
Novo Nordisk A/S has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
LY2140023
Novo Nordisk A/S
Schizophrenia
1 trial -
Matched Placebo
Novo Nordisk A/S
Mechanical allodynia
1 trial -
NNC6019-0001
Novo Nordisk A/S
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
1 trial -
Product
Novo Nordisk A/S
Women with an indication for IVF/ICSI
1 trial -
activated recombinant human factor VII
Novo Nordisk A/S
Acquired Bleeding Disorder
2 trials
Frequently asked questions
How many pipeline programs does Novo Nordisk A/S have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs